Bionano Genomics (BNGO) didn't quite "beat earnings" when it reported its Q1 2021 results on Thursday last week -- and that's okay. Bionano posted a $9.9 million net loss for the quarter, somewhat ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform ...

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better ...

Bionano Genomics, which has commercialized a genome analysis platform used in laboratories across the world, is acquiring software firm BioDiscovery in a $90 million deal intended to broaden the reach ...

Holmlin reiterated, "We are reiterating our full year 2025 revenue guidance of $26 million to $30 million. We expect the fourth quarter of 2025 revenues to be in the range of $7.5 million to $7.9 ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

BioNano Genomics, a San Diego maker of a genome mapping instrument, has raised $53 million. The company’s Irys System goes beyond the genomic DNA sequence to describe the location and order of ...

Holmlin provided updated full-year 2025 revenue guidance, stating "we expect full year revenues to be in the range of $26 million to $30 million which is an update compared to our previous views on ...

Bionano Genomics Inc. priced a $200 million underwritten stock offering announced late Tuesday at a discount of $6 a share, selling 33.3 million shares. The stock closed Tuesday at an alltime high of ...

Bionano Genomics (BNGO) didn't quite "beat earnings" when it reported its Q1 2021 results on Thursday last week -- and that's okay. Bionano posted a $9.9 million net loss for the quarter, somewhat ...